24:
408:
418:
413:
388:
327:
428:
423:
398:
313:
403:
353:
227:
254:
The products are marketed by partners of the company. The name
Synthon is not mentioned on the packaging.
159:
144:
324:
393:
286:
8:
263:
155:
281:
biologics made with the LEX System, BLX-301, a humanized and glyco-optimized anti-
331:
87:
62:
23:
247:
237:
167:
342:
154:
The company was founded in 1991 by
Jacques Lemmens and Marijn Oosterbaan, two
382:
223:
175:
294:
148:
278:
243:
209:
195:
163:
233:
219:
58:
179:
354:
Biolex Sells LEX System to
Synthon and Initiates Sale of Locteron(R)
199:
81:
54:
290:
270:
213:
191:
187:
274:
183:
171:
198:
with about 1,500 employees. The company is headquartered in
371:
343:
Synthon ontwikkelt nieuw medicijn tegen de ziekte van Crohn
282:
127:
314:
Pil
Genthon via omweg afgezet - Economie - de Volkskrant
356:
Press
Release: Biolex Therapeutics – Mon, May 7, 2012.
297:. The financial terms of the sale were not disclosed.
325:
Bird & Bird Wins Major Patent Battle for
Synthon
273:LEX System for manufacturing biopharmaceuticals in
269:In May 2012 Synthon announced that it bought the
380:
409:Pharmaceutical companies established in 1991
419:Biotechnology companies established in 2007
414:Pharmaceutical companies of the Netherlands
293:malignancies and BLX-155, a direct-acting
22:
262:In 2007 the company started developing
389:1991 establishments in the Netherlands
381:
205:Medications made by Synthon include:
13:
14:
440:
363:
226:for the symptomatic treatment of
429:Organisations based in Nijmegen
347:
336:
318:
307:
1:
424:Companies based in Gelderland
300:
287:non-Hodgkin's B-cell lymphoma
277:. The sale also included two
228:benign prostatic hyperplasia
7:
162:. Synthon is active in the
160:Radboud University Nijmegen
10:
445:
399:Generic drug manufacturers
257:
122:
112:
104:
94:
76:
68:
38:
30:
21:
42:September 17, 1991
404:Life sciences industry
44:; 32 years ago
149:generic human drugs
114:Number of employees
72:Dr. Jacques Lemmens
18:
330:2006-10-17 at the
264:biopharmaceuticals
16:
138:
137:
118:1,600 (2022)
436:
375:
374:
372:Official website
357:
351:
345:
340:
334:
322:
316:
311:
156:organic chemists
134:
131:
129:
52:
50:
45:
26:
19:
15:
444:
443:
439:
438:
437:
435:
434:
433:
379:
378:
370:
369:
366:
361:
360:
352:
348:
341:
337:
332:Wayback Machine
323:
319:
312:
308:
303:
260:
126:
115:
100:CEO Anish Mehta
97:
90:
88:The Netherlands
84:
63:The Netherlands
48:
46:
43:
12:
11:
5:
442:
432:
431:
426:
421:
416:
411:
406:
401:
396:
391:
377:
376:
365:
364:External links
362:
359:
358:
346:
335:
317:
305:
304:
302:
299:
259:
256:
252:
251:
248:antidepressant
241:
238:antidepressant
231:
217:
168:Czech Republic
147:that produces
136:
135:
124:
120:
119:
116:
113:
110:
109:
108:Pharmaceutical
106:
102:
101:
98:
95:
92:
91:
86:
80:
78:
74:
73:
70:
66:
65:
40:
36:
35:
34:Pharmaceutical
32:
28:
27:
9:
6:
4:
3:
2:
441:
430:
427:
425:
422:
420:
417:
415:
412:
410:
407:
405:
402:
400:
397:
395:
392:
390:
387:
386:
384:
373:
368:
367:
355:
350:
344:
339:
333:
329:
326:
321:
315:
310:
306:
298:
296:
292:
288:
285:antibody for
284:
280:
276:
272:
267:
265:
255:
249:
245:
242:
239:
235:
232:
229:
225:
224:alpha blocker
221:
218:
215:
211:
208:
207:
206:
203:
201:
197:
193:
189:
185:
181:
177:
176:United States
173:
169:
165:
161:
157:
152:
150:
146:
145:multinational
142:
133:
125:
121:
117:
111:
107:
103:
99:
93:
89:
83:
79:
75:
71:
67:
64:
60:
56:
41:
37:
33:
29:
25:
20:
394:Dutch brands
349:
338:
320:
309:
295:thrombolytic
268:
261:
253:
204:
153:
143:is a Dutch
140:
139:
77:Headquarters
279:preclinical
244:Fluvoxamine
210:Simvastatin
196:South Korea
164:Netherlands
383:Categories
301:References
289:and other
234:Paroxetine
220:Tamsulosin
96:Key people
59:Gelderland
49:1991-09-17
180:Argentina
328:Archived
200:Nijmegen
130:.synthon
105:Products
82:Nijmegen
55:Nijmegen
31:Industry
258:History
158:of the
141:Synthon
123:Website
69:Founder
47: (
39:Founded
17:Synthon
291:B-cell
271:Biolex
214:statin
192:Mexico
188:Russia
174:, the
166:, the
275:Lemna
184:Chile
172:Spain
283:CD20
246:(An
236:(An
222:(An
194:and
132:.com
266:.
212:(A
128:www
53:in
385::
202:.
190:,
186:,
182:,
178:,
170:,
151:.
85:,
61:,
57:,
250:)
240:)
230:)
216:)
51:)
Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.
